688266 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Suzhou Zelgen Biopharmaceuticals Co., Ltd. engages in the innovation, research, development, manufacturing, and commercialization of new medications. Its products include tablets and capsules of small molecule drugs and protein drugs, which are mainly for the treatments of cancer and hematologic diseases. The company was founded by Ze Lin Sheng, Hui Ping Lu, and Su Liu on March 18, 2009 and is headquartered in Kunshan, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
688266 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company